Zacks.com featured highlights include Neurocrine Biosciences, MYR Group, Block, Delek US Holdings and Dycom Industries
Neurocrine Biosciences and four other stocks stand out for strong relative price strength as investors look beyond AI leaders in the second half of 2026.
Zacks
More News
Petrobras Changes Diesel Pricing While Preserving Market Stability
PBR cuts its diesel price but ends an equal temporary discount, keeping distributor costs unchanged as Brazil scales back fuel subsidies.
Zacks
Best Momentum Stocks to Buy for July 1st
DK, CZFS, and ALH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 1, 2026.
Zacks
5 Relative Price Strength Stocks to Buy for the Second Half
NBIX, MYRG, XYZ, DK and DY show strong relative price strength, upbeat estimate revisions and solid fundamentals heading into the second half.
Zacks
New Strong Buy Stocks for July 1st
LIEN, DK, ALH, CVE and LEGH have been added to the Zacks Rank #1 (Strong Buy) List on July 1, 2026.
Zacks
Best Growth Stocks to Buy for July 1st
ALH, CBOE, and DK it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 1, 2026.
Zacks
Best Value Stocks to Buy for July 1st
ILPT, CVE and DK made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 1, 2026.
Zacks
Shell Signs New Engineering Framework Agreement With Chiyoda
SHEL signs a new agreement with Chiyoda to speed engineering support, improve project execution and strengthen delivery across global energy projects.
Zacks
Halliburton Teams Up With Shape Digital for AI Asset Management
HAL teams with Shape Digital to unify subsurface and operational data, helping operators improve production planning, reliability, safety and efficiency.
Zacks
Canadian Natural Resources' Stability Makes It a Wise Hold Right Now
CNQ benefits from low-cost operations, record production and vast reserves with a strong growth pipeline, but earnings face commodity price volatility, high capex and maintenance risks